Literature DB >> 30254054

Arrestins and G proteins in cellular signaling: The coin has two sides.

Vsevolod V Gurevich1, Eugenia V Gurevich2.   

Abstract

Several studies have suggested that arrestin-mediated signaling by GPCRs requires G protein activation; however, in this issue of Science Signaling, Luttrell et al. documented arrestin-dependent activation of ERK1/2 by a number of GPCRs. These studies do not contradict each other, but illustrate the complexity of cellular signaling that cannot and should not be reduced to simplistic models.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30254054      PMCID: PMC6390952          DOI: 10.1126/scisignal.aav1646

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  10 in total

Review 1.  'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors.

Authors:  L M Luttrell
Journal:  J Mol Endocrinol       Date:  2003-04       Impact factor: 5.098

Review 2.  Organization and regulation of mitogen-activated protein kinase signaling pathways.

Authors:  T P Garrington; G L Johnson
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

3.  Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK.

Authors:  Morgan O'Hayre; Kelsie Eichel; Silvia Avino; Xuefeng Zhao; Dana J Steffen; Xiaodong Feng; Kouki Kawakami; Junken Aoki; Karen Messer; Roger Sunahara; Asuka Inoue; Mark von Zastrow; J Silvio Gutkind
Journal:  Sci Signal       Date:  2017-06-20       Impact factor: 8.192

Review 4.  Beta-arrestins and cell signaling.

Authors:  Scott M DeWire; Seungkirl Ahn; Robert J Lefkowitz; Sudha K Shenoy
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

Review 5.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

6.  Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant.

Authors:  Maya Breitman; Seunghyi Kook; Luis E Gimenez; Britney N Lizama; Maria C Palazzo; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

7.  Peptide mini-scaffold facilitates JNK3 activation in cells.

Authors:  Xuanzhi Zhan; Henriette Stoy; Tamer S Kaoud; Nicole A Perry; Qiuyan Chen; Alejandro Perez; Sylvia Els-Heindl; Jack V Slagis; Tina M Iverson; Annette G Beck-Sickinger; Eugenia V Gurevich; Kevin N Dalby; Vsevolod V Gurevich
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

8.  Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.

Authors:  Elisa Alvarez-Curto; Asuka Inoue; Laura Jenkins; Sheikh Zahir Raihan; Rudi Prihandoko; Andrew B Tobin; Graeme Milligan
Journal:  J Biol Chem       Date:  2016-11-16       Impact factor: 5.157

9.  Lack of beta-arrestin signaling in the absence of active G proteins.

Authors:  Manuel Grundmann; Nicole Merten; Davide Malfacini; Asuka Inoue; Philip Preis; Katharina Simon; Nelly Rüttiger; Nicole Ziegler; Tobias Benkel; Nina Katharina Schmitt; Satoru Ishida; Ines Müller; Raphael Reher; Kouki Kawakami; Ayumi Inoue; Ulrike Rick; Toni Kühl; Diana Imhof; Junken Aoki; Gabriele M König; Carsten Hoffmann; Jesus Gomeza; Jürgen Wess; Evi Kostenis
Journal:  Nat Commun       Date:  2018-01-23       Impact factor: 14.919

10.  Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9.

Authors:  Louis M Luttrell; Jialu Wang; Bianca Plouffe; Jeffrey S Smith; Lama Yamani; Suneet Kaur; Pierre-Yves Jean-Charles; Christophe Gauthier; Mi-Hye Lee; Biswaranjan Pani; Jihee Kim; Seungkirl Ahn; Sudarshan Rajagopal; Eric Reiter; Michel Bouvier; Sudha K Shenoy; Stéphane A Laporte; Howard A Rockman; Robert J Lefkowitz
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 9.517

  10 in total
  11 in total

Review 1.  Many faces of the GPCR-arrestin interaction.

Authors:  Kiae Kim; Ka Young Chung
Journal:  Arch Pharm Res       Date:  2020-08-14       Impact factor: 4.946

Review 2.  Arrestin recruitment and signaling by G protein-coupled receptor heteromers.

Authors:  Kendall L Mores; Robert J Cassell; Richard M van Rijn
Journal:  Neuropharmacology       Date:  2018-11-09       Impact factor: 5.250

3.  Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor.

Authors:  Ali I Kaya; Nicole A Perry; Vsevolod V Gurevich; T M Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-05       Impact factor: 11.205

Review 4.  Biased GPCR signaling: Possible mechanisms and inherent limitations.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

Review 5.  GPCR Signaling Regulation: The Role of GRKs and Arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

Review 6.  G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub.

Authors:  Petronila Penela; Catalina Ribas; Francisco Sánchez-Madrid; Federico Mayor
Journal:  Cell Mol Life Sci       Date:  2019-08-20       Impact factor: 9.261

Review 7.  GRKs as Modulators of Neurotransmitter Receptors.

Authors:  Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

Review 8.  QR code model: a new possibility for GPCR phosphorylation recognition.

Authors:  Hao Chen; Suli Zhang; Xi Zhang; Huirong Liu
Journal:  Cell Commun Signal       Date:  2022-03-02       Impact factor: 5.712

Review 9.  New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis.

Authors:  Anna Bagnato; Laura Rosanò
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

Review 10.  GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease.

Authors:  Hanne Leysen; Deborah Walter; Bregje Christiaenssen; Romi Vandoren; İrem Harputluoğlu; Nore Van Loon; Stuart Maudsley
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.